Duncan Porter

4.5k total citations · 1 hit paper
65 papers, 2.7k citations indexed

About

Duncan Porter is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Duncan Porter has authored 65 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Rheumatology, 19 papers in Hematology and 11 papers in Genetics. Recurrent topics in Duncan Porter's work include Rheumatoid Arthritis Research and Therapies (48 papers), Systemic Lupus Erythematosus Research (23 papers) and Autoimmune and Inflammatory Disorders Research (17 papers). Duncan Porter is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (48 papers), Systemic Lupus Erythematosus Research (23 papers) and Autoimmune and Inflammatory Disorders Research (17 papers). Duncan Porter collaborates with scholars based in United Kingdom, Canada and United States. Duncan Porter's co-authors include A. Stirling, W. Kincaid, Alex D. McMahon, R. Vallance, Hilary A. Capell, Peter Lock, Iain B. McInnes, H A Capell, Robin Munro and James Dale and has published in prestigious journals such as The Lancet, PLoS ONE and Scientific Reports.

In The Last Decade

Duncan Porter

64 papers receiving 2.6k citations

Hit Papers

Effect of a treatment strategy of tight control for rheum... 2004 2026 2011 2018 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
    2004 1.0k citations Hilary A. Capell, A. Stirling et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duncan Porter United Kingdom 26 2.2k 918 497 429 341 65 2.7k
Cătălin Codreanu Romania 19 943 0.4× 402 0.4× 333 0.7× 195 0.5× 170 0.5× 67 1.6k
Geraldo da Rocha Castelar Pinheiro Brazil 22 849 0.4× 416 0.5× 220 0.4× 149 0.3× 148 0.4× 87 1.5k
Don Robinson United States 21 724 0.3× 364 0.4× 593 1.2× 61 0.1× 168 0.5× 39 1.9k
W. Bencivelli Italy 25 877 0.4× 135 0.1× 524 1.1× 36 0.1× 833 2.4× 59 2.4k
Stefania Galimberti Italy 28 185 0.1× 556 0.6× 264 0.5× 243 0.6× 77 0.2× 109 2.7k
Jeffrey J. Swigris United States 39 1.2k 0.6× 78 0.1× 317 0.6× 107 0.2× 1.1k 3.3× 103 7.7k
Lijun Liu China 22 176 0.1× 336 0.4× 341 0.7× 107 0.2× 278 0.8× 80 1.7k
Deepak Bansal India 26 184 0.1× 886 1.0× 108 0.2× 526 1.2× 203 0.6× 248 2.5k
Finn Wesenberg Norway 28 128 0.1× 738 0.8× 164 0.3× 181 0.4× 113 0.3× 87 2.2k
Raymond J. Hutchinson United States 42 172 0.1× 1.6k 1.8× 784 1.6× 513 1.2× 648 1.9× 136 5.6k

Countries citing papers authored by Duncan Porter

Since Specialization
Citations

This map shows the geographic impact of Duncan Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan Porter more than expected).

Fields of papers citing papers by Duncan Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan Porter. The network helps show where Duncan Porter may publish in the future.

Co-authorship network of co-authors of Duncan Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Duncan Porter. A scholar is included among the top collaborators of Duncan Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan Porter. Duncan Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nijjar, Jagtar Singh, Derek S. Gilchrist, Duncan Porter, et al.. (2023). JAK inhibitors disrupt T cell-induced proinflammatory macrophage activation. RMD Open. 9(1). e002671–e002671. 11 indexed citations
4.
Porter, Duncan, Neil Basu, & Stefan Siebert. (2020). Classification criteria: time for a rethink?. Annals of the Rheumatic Diseases. 79(10). 1264–1266. 6 indexed citations
5.
Dale, James, A. Stirling, Ruiqi Zhang, et al.. (2016). Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Annals of the Rheumatic Diseases. 75(6). 1043–1050. 147 indexed citations
6.
Porter, Duncan, James Dale, Claudia‐Martina Messow, et al.. (2016). Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial. The Lancet. 388(10041). 239–247. 85 indexed citations
7.
Dale, James, Caron Paterson, Ann Tierney, et al.. (2016). The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank. BMC Musculoskeletal Disorders. 17(1). 461–461. 23 indexed citations
8.
Stalmach, Angélique, Iain B. McInnes, Holger Husi, et al.. (2014). Identification of Urinary Peptide Biomarkers Associated with Rheumatoid Arthritis. PLoS ONE. 9(8). e104625–e104625. 28 indexed citations
9.
Porter, Duncan, James Dale, & Naveed Sattar. (2013). How low to aim in rheumatoid arthritis? Learning from other disciplines. Annals of the Rheumatic Diseases. 73(3). 480–482. 7 indexed citations
10.
Béresniak, Ariel, Jürgen Braun, Paolo Angelo Cortesi, et al.. (2012). Treat-to-Target in Rheumatoid Arthritis: Clinical and PharmacoEconomic Considerations. Clinical and Experimental Rheumatology. 30. 3 indexed citations
11.
Capell, Hilary A., A. Stirling, Alex D. McMahon, et al.. (2004). Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. The Lancet. 364(9430). 263–269. 1029 indexed citations breakdown →
12.
Hamilton, Jennifer D., et al.. (2000). Lifestyle Influences on Outcome in Rheumatoid Arthritis. Scottish Medical Journal. 45(5). 137–139. 8 indexed citations
13.
Irvine, S. Rodman, Robin Munro, & Duncan Porter. (1999). Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Annals of the Rheumatic Diseases. 58(8). 510–513. 84 indexed citations
14.
Munro, Robin, et al.. (1998). Lymphadenopathy in a patient with systemic onset juvenile chronic arthritis. Annals of the Rheumatic Diseases. 57(9). 513–517. 14 indexed citations
15.
Fleming, Colin, Duncan Porter, & Rona M. MacKie. (1998). Absence of gold sodium thiosulfate contact hypersensitivity in rheumatoid arthritis. Contact Dermatitis. 38(1). 55–56. 4 indexed citations
16.
Reglinski, J., Duncan E. Paterson, Rhoda Wilson, et al.. (1997). Myocrisin-mediated oxidative stress. Clinica Chimica Acta. 268(1-2). 85–99. 8 indexed citations
17.
McEntegart, Anne, et al.. (1997). Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 56(7). 410–413. 67 indexed citations
18.
19.
Porter, Duncan & R D Sturrock. (1993). Medical management of rheumatoid arthritis.. BMJ. 307(6901). 425–428. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cătălin Codreanu Breakdown of academic impact, for papers by Geraldo da Rocha Castelar Pinheiro Breakdown of academic impact, for papers by Don Robinson Breakdown of academic impact, for papers by W. Bencivelli Breakdown of academic impact, for papers by Stefania Galimberti Breakdown of academic impact, for papers by Jeffrey J. Swigris Breakdown of academic impact, for papers by Lijun Liu Breakdown of academic impact, for papers by Deepak Bansal Breakdown of academic impact, for papers by Finn Wesenberg Breakdown of academic impact, for papers by Raymond J. Hutchinson
Rankless by CCL
2026